Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease ...

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use co ...

From subtle rashes to sun-safety strategies, Drs Maureen McMahon and John Edminister discuss how to recognize cutaneous lupus and protect patients from UV-triggered flares.

An illustration of a magnifying glass. An illustration of a magnifying glass.

and oral lichenoid lesions related to dental amalgam. Nineteen specimens of OLP, OLLC, and healthy oral mucosa were selected. Mononuclear inflammatory cells were analyzed. Histochemical and ...

Oral cancer cases are on the rise across the globe. Oral cancer, affecting the mouth, lips, tongue, or throat, claims ...

With three design patents to his credit, his contributions are reshaping how clinicians approach oral lesion analysis. "Early detection is paramount in reducing morbidity and mortality rates ...

Oral lesions not associated with active disease occur in up to 40% of people with lupus and are usually a result of a reaction to a drug being used to treat lupus or another condition. They have a non ...

SALT LAKE CITY — In this video, Jay Chhablani, MD, professor of ophthalmology at University of Pittsburgh School of Medicine, discusses 24-month findings from the SAGA trial evaluating oral ...

A total of 1,052 volunteers were evaluated. Oral mucosal lesions were observed in 42.11%, variations of normal structures in 38.50%, and xerostomia in 60.64%. Women were more affected than men, ...